News
The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, according to a press release from the manufacturer. There are currently no ...
Hosted on MSN1mon
JNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's DiseaseBesides SjD, the FDA has granted FTD to nipocalimab in three other indications, hemolytic disease of the fetus and newborn (“HDFN”) and warm autoimmune hemolytic anemia (wAIHA), generalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback